Biomarker Detection
Antibodies, ELISA kits, proteins and controls for thyroid cancer markers.
Explore research-use products for thyroid tumor biology, papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, anaplastic thyroid cancer, BRAF/MAPK signaling, RET alterations, RAS-like biology, NTRK fusions, TERT/TP53 progression, thyroglobulin, calcitonin, TPO, NIS/SLC5A5, iodine-handling research, lymph-node spread, endocrine tumor models and functional assay workflows.
Build thyroid tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.
Primary antibodies for thyroglobulin, calcitonin, TPO, NIS, BRAF, RET, PAX8, NKX2-1/TTF-1, Ki-67, galectin-3, cytokeratins and thyroid tumor markers.
View antibodiesKits and assays for thyroglobulin, calcitonin, CEA, TSH-related pathways, cytokines, angiogenesis markers, inflammation and endocrine tumor research.
View ELISA kitsRecombinant proteins, calibrators and controls for assay development, antibody validation, pathway stimulation and endocrine biomarker workflows.
View proteinsMolecular tools for BRAF, RAS, RET, NTRK, TERT, TP53, PAX8/PPARG, iodine-handling genes, EMT, invasion, differentiation and thyroid cancer subtype profiling.
View molecular toolsMedia, matrices, supplements, transfection reagents and model-system tools for thyroid cancer cells, endocrine tumor models, spheroids and resistance studies.
View culture toolsATP, cytotoxicity, apoptosis, proliferation, invasion, migration, DNA damage, oxidative stress, kinase-response and targeted-therapy assay systems.
View assay toolsThyroid cancer research often studies driver genes, endocrine differentiation, C-cell biology, iodine transport, tumor proliferation, recurrence markers and progression markers.
BRAF is widely studied in papillary thyroid cancer, MAPK activation, differentiation state, invasion and targeted-response research.
RET mutations are central in medullary thyroid cancer research, while RET fusions are studied in differentiated thyroid tumor biology.
Thyroglobulin is a follicular-cell marker used in differentiated thyroid cancer research and assay-development contexts.
Calcitonin is a C-cell marker central to medullary thyroid cancer research and quantitative assay workflows.
Choose a workflow and get product groups matched to thyroid tumor research needs.
Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, thyroglobulin, calcitonin, TPO, NIS, PAX8, NKX2-1/TTF-1, BRAF, RET, Ki-67, galectin-3 and cytokeratin markers.
Browse tissue research productsUse thyroid tumor research products across biomarker discovery, assay validation, molecular pathway analysis, endocrine differentiation, invasion studies and drug-response models.
Study BRAF, RET fusions, NTRK fusions, MAPK signaling, lymph-node spread and differentiation markers.
Analyze RAS-like biology, PAX8/PPARG, capsular invasion, vascular invasion and iodine-handling genes.
Study RET mutations, C-cell biology, calcitonin, CEA and endocrine tumor signaling.
Measure TP53, TERT, dedifferentiation, invasion, drug response and aggressive progression markers.
Study NIS/SLC5A5, TPO, thyroglobulin, differentiation state and radioiodine-resistance biology.
Measure viability, apoptosis, kinase response, cytotoxicity, DNA damage, invasion and resistance.
Product selection should match the biological target, thyroid cancer subtype, sample type, assay format and validation requirements.
Examples: BRAF/MAPK signaling, RET biology, calcitonin quantification, iodine-handling genes or dedifferentiation.
Review whether the product is relevant for papillary, follicular, medullary, anaplastic or differentiated thyroid cancer research.
Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.
Include positive controls, negative controls, calibrators, reference lysates, recombinant standards and reproducibility checks.
Explore research-use tools for thyroid tumor biomarkers, BRAF/MAPK signaling, RET biology, iodine-handling pathways, medullary thyroid cancer markers, anaplastic progression, cell models and experimental drug-response workflows.
Clear answers to common product-selection and thyroid tumor workflow questions.
Thyroid cancer research products are laboratory-use reagents and assay tools used to study thyroid tumor biology, endocrine differentiation, BRAF/MAPK signaling, RET biology, iodine-handling pathways, tumor markers, cell models and drug response.
Frequently studied biomarkers include BRAF, RET, RAS, NTRK, TERT, TP53, thyroglobulin, calcitonin, CEA, TPO, NIS/SLC5A5, PAX8, NKX2-1/TTF-1, Ki-67 and galectin-3.
Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, endocrine markers, proliferation markers, driver-pathway markers and subtype-specific thyroid tumor markers.
No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.
Authoritative sources supporting thyroid cancer biology, biomarkers and research context.